©1996 by The American Society for Biochemistry and Molecular Biology, Inc.
The Isoform of Protein Kinase C Mediates Transcriptional Activation of the Human Transglutaminase 1 Gene (*)

(Received for publication, November 20, 1995; and in revised form, January 22, 1996)

Eiichiro Ueda (1) Shigeo Ohno (2) Toshio Kuroki (3) Etta Livneh (4) Keiko Yamada (1) Kiyofumi Yamanishi (1)(§) Hirokazu Yasuno (1)

From the  (1)Department of Dermatology, Kyoto Prefectural University of Medicine, Kamigyo-ku, Kyoto 602, the (2)Department of Molecular Biology, Yokohama City University, School of Medicine, Kanazawa-ku, Yokohama 236, the (3)Department of Cancer Cell Research, Institute of Medical Science, University of Tokyo, Minato-ku, Tokyo 108, Japan, and the (4)Department of Chemical Immunology, the Weizmann Institute of Science, Rehovot 76100, Israel

ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
FOOTNOTES
REFERENCES

ABSTRACT

Transglutaminase 1 (TGase 1) is expressed during the terminal differentiation of keratinized squamous epithelium to form cornified cell envelope in differentiated keratinocytes by the -(-glutamyl) cross-linking reaction. The gene for human TGase 1 is responsible for autosomal recessive lamellar ichthyosis, a severe hereditary keratinizing disorder of the skin. We examined the transcriptional activity of the gene in FRSK, rat keratinocytic cells, transfected with the luciferase reporter gene under control of the 5` upstream region of human TGase 1 gene. Transfection of the reporter gene with an expression vector for the isoform of novel protein kinase C (nPKC), as well as exposure to 12-O-tetradecanoylphorbol-13-acetate, markedly increased the luciferase activity in FRSK, but not in HT-1080 fibrosarcoma cells, although exogenous nPKC was expressed in both. The induction was suppressed by deleting the TGase 1 upstream sequence from -95 to -67 and by deleting the kinase domain from exogenous nPKC. In comparison with other PKC isoforms, nPKC most effectively induced the luciferase activity. We suggest that nPKC, an epithelium-specific isoform of PKC, mediates the activation of the TGase 1 transcription.


INTRODUCTION

Terminal differentiation is a highly organized biological process that involves the programmed death of cells(1) . The epidermis covering the most outer layer of the skin is maintained by a dynamic equilibrium of renewal with terminal differentiation of keratinocytes, the major cell lineage of the epidermis. This process, keratinization, proceeds with the ordered expression of genes in keratinocytes and their morphological changes. Transglutaminase 1 (TGase 1), (^1)a member of the transglutaminase family (EC 2.3.2.13), is expressed during keratinization(2, 3, 4) . The enzyme catalyzes the -(-glutamyl) lysine cross-linking reaction of the proteins, such as involucrin(5) , cystatin-alpha(6) , loricrin, small proline-rich proteins, and elafin(7) , and forms the cornified cell envelope on the inner surface of the differentiated keratinocytes (4) . This insoluble structure maintains the internal milieu and protects the body against the chemical, mechanical, and biological invasion. The importance of this enzyme in the morphogenesis and barrier function of the skin has been shown also by discovery of its mutation in autosomal recessive lamellar ichthyosis(8, 9, 10) , which is a hereditary keratinization disorder characterized by collodion baby at birth and later, severe ichthyosis with large brownish plate-like desquamations and epidermal hyperkeratosis, ectropion, eclabium, and scarring alopecia.

The gene for human TGase 1 is located on 14q11.2 (11, 12) and encodes a 92-kDa protein consisting of 816 amino acid residues (13, 14, 15) . In the epidermis of the skin, TGase 1 gene is expressed mainly in the subcorneal granular layers(16, 17, 18) . The enzyme activity of transglutaminase is enhanced by treating primary mouse epidermal cells with 12-O-tetradecanoylphorbol-13-acetate (TPA), an activator of protein kinase C(19) . In cultured epidermal keratinocytes and tracheal epithelial cells, the level of TGase 1 mRNA is increased also by TPA (20, 21) as well as Ca(22, 23, 24) , ganglioside GQ(24) , and interferon-(25) . Besides the effect of TPA, the critical function of PKC in the regulation of TGase 1 gene expression has been suggested by studies using several PKC inhibitors(20, 26) . However, there is no direct evidence indicating that PKC mediates the signal for the transcriptional activation of TGase 1.

PKC was initially characterized as a serine/threonine-type protein kinase, the activity of which is dependent on Ca, phospholipids, and diacylglycerol(27, 28, 29) . Subsequently, various isoforms of the enzyme have been identified(30) . PKC is now classified into three major subgroups, Ca-, phospholipid-, and diacylglycerol-dependent classical PKCs (cPKC) (alpha, betaI, betaII, and ), Ca-independent novel PKCs (nPKC) (, , , and ) and Ca- and diacylglycerol-independent atypical PKC (aPKC) ( and /). In addition, the µ isoform, a membrane-bound PKC, has been identified(31) . They differ in terms of tissue distribution and are involved in a variety of specialized functions of the tissues. One nPKC, called nPKC (PKC-L), is epithelium-specific(32, 33) . Although there are also other PKC isoforms, such as cPKCalpha and nPKC, in the epidermis of the skin (34) , the localization of nPKC in the subcorneal granular layer is quite similar to that of TGase 1 mRNA(16, 17) , suggesting that it mediates the activation signal for TGase 1 gene during the terminal differentiation of epidermal keratinocytes. Understanding the unique signal transduction for TGase 1 gene regulation should provide new insight into the molecular mechanism involved in the complex biological process of keratinization. Therefore, we analyzed the role of nPKC in the transcriptional activation of TGase 1 gene expression.


EXPERIMENTAL PROCEDURES

Materials

FRSK cells (35, 36) and HT-1080 fibrosarcoma cells (37) were supplied by the Japanese Cancer Research Resources Bank (Foundation for Promotion of Cancer Research, Tokyo, Japan). The luciferase reporter plasmids PGV-B and PGV-C were purchased from Toyo Ink Manufacturing Co., Ltd. and 12-O-tetradecanoylphorbol-13-acetate was obtained from LC Service Corp. Oligonucleotides were synthesized using a DNA synthesizer (model 392; Applied Biosystems, Inc.). All other reagents and chemicals were purchased from commercial sources and were either of reagent grade or the highest purity available.

Cell Culture

FRSK cells were cultured in Eagle's minimum essential medium supplemented with 10% fetal calf serum, and HT-1080 cells were cultured in the same medium containing nonessential amino acids (ICN Biochemicals Inc.) at 37 °C under 5% CO(2) in air. Cells were subcultured every 3-4 days until they reached 80% confluence.

Construction of Reporter Plasmids

Deletion fragments of the 5` upstream region of human TGase 1 gene from -819 to -49 were generated by the polymerase chain reaction (PCR) using a plasmid pd1L as the template(38) . These fragments were amplified using UlTma DNA polymerase (Perkin-Elmer) and synthetic oligonucleotide primers, according to the manufacturer's instruction. These PCR products and the synthesized oligonucleotides for -20 deletion were inserted into the SmaI site of PGV-B, a luciferase reporter plasmid containing neither enhancer nor promoter sequences. These reporter plasmids are summarized in Fig. 1. PGV-C is a constitutive expression plasmid for luciferase containing the SV40 promoter and enhancer.


Figure 1: The TGase 1-luciferase reporter genes. Deletions of the human TGase 1 5` flanking region from -819 to -49 were generated by PCR and inserted into the SmaI site of PGV-B, a basic luciferase reporter vector. PGV-C is a constitutive expression vector for luciferase driven by SV40 promoter and enhancer. Arrows indicate PCR primers used to synthesize the deletion mutants. Upper primers are as follows: pd-819, aattccaggttggagaaaagg; pd-95, cccatttcccgcccagaggcc; pd-66, tctctccgccccctacagcag; pd-49, gcagtttggcccctccctccc. The lower primer is tcacttaccaggtctgtccct. This primer was also used to prepare the deletion fragment pd-20, by annealing it with its sense oligonucleotide. E, EcoRI; P, PvuII; B, BamHI; H, HindIII; Luc, luciferase gene; SV40 box, SV40 enhancer; P box, SV40 promoter.



Construction of SRDRD

The kinase domain of mouse nPKC is encoded by a 865-bp sequence from nucleotides 1041-1905 of the cDNA(33) . SRD, an expression plasmid containing the complete coding sequence for mouse nPKC(33) , was digested with EcoRI and SalI. The 1.0-kb fragment encoding the E region and the regulatory domain of the enzyme was inserted into the EcoRI site of pcDL-SRalpha296, the backbone of SRD (39) .

Transient Expression Assay

Cells were seeded at a density of 6 times 10^4 cells/2 ml of medium in 35-mm dishes and incubated at 37 °C under 5% CO(2) in air. Two days later, the DNA was transfected into the cells by lipofection using N-[1-(2,3-dioleoyloxy)propyl]-N,N,N-trimethylammonium methylsulfate (DOTAP) (Boehringer Mannheim), according to the manufacturer's instructions. Transfected DNA consisted of 1 µg of reporter plasmid with or without expression plasmids, 0.1 µg of pCMVbeta (40) as an internal control for variation in transfection efficiencies, and the appropriate amount of pGEM3Z (Promega) to standardize the total amount of DNA. After an incubation at 37 °C for 16 h, the medium was changed and 20 h later the cells were exposed or not to 1 nM TPA for 4 h, then harvested for luciferase and beta-galactosidase assays or processed for immunoblotting. Luciferase activity was assayed with a PicaGene kit (PGK-L500, Toyo Ink Manufacturing Co., Ltd.) using a Monolight 2010 luminometer (Analytical Luminescence Laboratory). We determined beta-galactosidase activity using a beta-galactosidase enzyme assay system (Promega) and a microplate reader (model 450, Bio-Rad). The experiment was repeated at least three times, and representative results are shown in the figures. The luciferase activities from duplicate experiments were normalized relative to beta-galactosidase activities and protein concentrations.

Immunoblotting Analysis

Cells were immersed in 10% trichloroacetic acid at 4 °C for 15 min, then scraped off the dishes. After centrifugation at 10,000 times g for 5 min, the trichloroacetic acid was removed and the pellet was homogenized in 80 µl of Urea-TX (9 M urea, 2% Triton X-100, 5% 2-mercaptoethanol) by sonication on ice. To this, 20 µl of 10% lithium dodecyl sulfate and 1 µl of 2 M Tris were added, then the proteins were separated on 10% sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE)(41) . The separated proteins were electrically transferred onto a Clearblot-P membrane (Atto Corp.). The blot was probed with anti-PKCalpha antibody (Life Technologies, Inc.), anti-nPKC antibody (Santa Cruz Biotechnology, Inc.), and anti-nPKC antibody(42) . The protein was detected using second anti-rabbit IgG antibody conjugated with alkaline phosphatase (Bio-Rad).


RESULTS

The Transcriptional Activity of the 5`-Upstream Region of Human TGase 1 Gene

FRSK is a keratinocytic cell line derived from fetal rat skin(35, 36) . FRSK cells, like HaCaT cells derived from a human epidermoid carcinoma, are grown in medium with a normal Ca concentration. We have studied the transcriptional regulation of human TGase 1 gene by means of electroporation(38) . In this study, we adopted lipofection using DOTAP, because the transfection efficiency of this procedure was 10-fold higher than that of electroporation. There was practically no difference in the transcriptional activities between the 2.5-kb and 819-bp upstream regions of TGase 1 gene(38) . Therefore, we examined the activity of the region up to -819 of the gene. When the luciferase reporter plasmid pd-819 containing the 819-bp upstream sequence of human TGase 1 gene was transfected into FRSK cells by lipofection, there was substantial basal luciferase activity (Fig. 2A). The activity was potentiated by 1 nM TPA, which induces the expression of TGase 1 mRNA in keratinocytes(20) . To assess the sequence required for the transcriptional activation of the gene, we prepared deletion mutants of its 5` upstream region from -819 to -20 and luciferase reporter plasmids containing these sequences were transfected into FRSK cells. As shown in Fig. 2A, the luciferase activity remained even when the sequence from -819 to -96 was deleted from the upstream region. However, the major loss of TPA-stimulated luciferase activity was seen when the sequence between -95 and -67 was deleted. A deletion from -66 to -50 substantially reduced the basal luciferase activity. These results suggest that the induction of TGase 1 gene expression by TPA is regulated at the transcriptional level and that this 29-bp 5` upstream sequence is required for the signaling.


Figure 2: The transcriptional activation of the human TGase 1 gene by TPA and nPKC. A, the effect of TPA on the transcriptional activity of human TGase 1. The TGase 1-luciferase reporter genes were transfected into FRSK, cultured rat keratinocytes. After a 2-day incubation, the cells were exposed or not to 1 nM TPA for 4 h, and then the luciferase activity was determined, as described under ``Experimental Procedures.'' B, the effect nPKC on the transcriptional activity of human TGase 1. SRD, an expression plasmid for nPKC, was co-transfected with the reporter genes into FRSK cells; 2 days later, the luciferase activity was determined. Data represent the means of duplicate experiments normalized to beta-galactosidase activity. PGV-B and PGV-C are negative and positive control reporter plasmids, respectively.



The Activation of Human TGase 1 Transcription by nPKC

Of the PKC family, the localization of nPKC is closely related to that of TGase 1 mRNA in human epidermis(16, 17, 34, 43) , implying that it is involved in the induction of TGase 1 transcription. To investigate this notion, we co-transfected SRD(33) , an expression plasmid for mouse nPKC, into FRSK cells with the same set of reporter constructs used for the experiment described above. As shown in Fig. 2B, the co-transfection of SRD with pd-819 increased the luciferase activity and the induction was comparable to that by TPA. The effect of the co-transfection was abolished by deleting the 5`-upstream sequence from -95 to -67, which was the same region required for the effect of TPA. These findings indicated that nPKC mediates the activation of TGase 1 transcription.

The Effect of nPKC on the TGase 1 Transcription in Different Cell Types

To study the dose-responsive effect of nPKC, various amounts of SRD were transfected into FRSK cells with the reporter plasmid pd-95, which contains the minimum proximal upstream sequence responsive to both TPA and nPKC. As shown in Fig. 3A, the increase in the luciferase activity was maximal at 12.5 and up to 500 fmol of SRD. The level of the induction by SRD was similar to that elicited by co-transfection with 500 fmol of pL27, an expression plasmid for human nPKC (44) .


Figure 3: The comparison of the effects of nPKC on the transcriptional activation of human TGase 1 gene between FRSK cells and HT-1080 cells. A reporter gene, pd-95, was co-transfected with the indicated amounts of SRD into FRSK cells (A) or into HT-1080 fibrosarcoma cells (B), after which the luciferase activity was determined, as described under ``Experimental Procedures.'' pL27 is an expression vector for human nPKC (PKC-L). Data represent the means of duplicate experiments normalized to beta-galactosidase activity.



In contrast to FRSK cells, TPA fails to activate TGase 1 transcription in HT-1080, a human fibrosarcoma cell line, even when a reporter plasmid containing -819 upstream sequences is transfected(38) . When pd-95 was co-transfected with SRD from 2.5 to 25 fmol into HT-1080 cells, the induction of luciferase activity remained at low levels (Fig. 3B), indicating that the machinery that transduces the signal elicited by nPKC is defective in HT-1080 cells.

Deletion of the Kinase Domain of nPKC Abolishes Its Effect on Human TGase 1 Gene

The enzyme nPKC is composed of a regulatory and a kinase domain. Unlike classical PKCs, the regulatory domain of nPKC has no Ca binding subdomain, but its kinase domain is homologous to those of other PKCs. To study the role of the kinase domain of nPKC in the activation of TGase 1 transcription, we constructed the plasmid SRDRD from SRD by deleting the cDNA sequence encoding this domain and co-transfected this plasmid with pd-95 into FRSK cells. SRDRD did not induce luciferase activity over the basal level (Fig. 4). TPA caused no additional increase in the luciferase activity in FRSK cells transfected with SRDRD as well as SRD. Thus, nPKC is essential for TGase 1 gene expression and possibly the kinase domain of the enzyme is involved in the signaling for the transcription.


Figure 4: The effect of mutant SRD on the human TGase 1 transcriptional activity in FRSK cells. A reporter gene pd-95 was co-transfected into FRSK cells with 12.5 fmol of either SRD or SRDRD, a mutant SRD with deletion in the sequence encoding the kinase domain of nPKC, as described under ``Experimental Procedures.'' After 2 days of incubation, the cells were incubated with or without 1 nM TPA for 4 h, and then luciferase activity was determined. Data represent the means of duplicate experiments normalized to beta-galactosidase activity.



Expression of PKC Isoforms by Transfection with Their Expression Plasmids

The effect of nPKC expression on human TGase 1 transcription was almost a plateau, when over 12.5 fmol of SRD were transfected into FRSK cells (Fig. 3A). This might be due to the limitation on the expression level of exogenous nPKC in FRSK cells. A similar mechanism might lead to low levels of activation of TGase 1 transcription in HT-1080 cells transfected with SRD. These possibilities were ruled out by immunoblotting extracts from the cells transfected with SRD using an anti-nPKC antibody, which was raised against a peptide corresponding to a 15-amino acid sequence within the C terminus of the enzyme. An 82-kDa band corresponding to exogenous nPKC was detected in both FRSK (Fig. 5A) and HT-1080 cells (Fig. 5B). The level of nPKC expression was increased depending on the amount of transfected SRD, at least, in the range up to 250 fmol. We examined the expression of the PKC isoforms PKCalpha and PKC in FRSK cells transfected or not with each expression plasmid(33, 39, 42) . As shown in Fig. 5(C and D), the increases in the expression of these PKC isoforms were also dose-dependent. In the range up to 250 fmol of these effector plasmids, there was no limitation on the expression of the exogenous proteins.


Figure 5: PKC isoform expression in FRSK and HT-1080 cells transfected with PKC expression vectors. Seven micrograms of proteins extracted from the cells transfected with SRD vector or with various amounts of PKC expression vectors were separated by SDS-PAGE, transferred to a nylon membrane, and reacted with antiserum against nPKC (A and B), cPKCalpha (C), and nPKC (D), as described under ``Experimental Procedures.'' Lane 1, no transfection; lane 2, transfection with 500 fmol of SRD vector; lanes 3-6, transfection with 25, 125, 250, and 500 fmol of PKC expression vectors, respectively; lane 7, transfection with 500 fmol of pL27 encoding human nPKC.



Comparison of the Effect of nPKC with Other PKC Isoforms on the Human TGase 1 Transcription

In epidermal keratinocytes, at least cPKCalpha, nPKC, and nPKC are expressed(34, 45) . cPKCbetaII is found in Langerhans cells of the skin as well as other organs(46) , and cPKC is predominantly expressed in the brain. aPKC isoform is expressed in a variety of tissues(47) . In addition to nPKC, we examined the effects of other PKC isoforms on TGase 1 transcription in FRSK cells. The expression plasmids for cPKCalpha, cPKCbetaII, cPKC, nPKC, nPKC, or aPKC (33, 39, 42) were co-transfected with pd-95, and the luciferase activity was compared. As shown in Fig. 6F, nPKC most efficiently induced luciferase activity. Next to nPKC, nPKC was also effective (Fig. 6E). However, cPKCalpha, cPKCbetaII, cPKC, and aPKC hardly induced the luciferase activity (Fig. 6, A-D and G). Thus, among the PKC isoforms examined, nPKC was the most efficient activator of human TGase 1 transcription.


Figure 6: The effects of PKC isoforms on the TGase 1 transcriptional activity. The reporter pd-95 was co-transfected with the indicated amounts of SRD vector (mock) (A), and expression vectors for cPKCalpha (B), cPKCbetaII (C), cPKC (D), nPKC (E), nPKC (F), and aPKC (G) into FRSK cells. After 2 days, luciferase activity was assayed as described under ``Experimental Procedures.'' Data represent the means of duplicate experiments normalized to beta-galactosidase activity.




DISCUSSION

Several reports have provided evidence that PKC regulates TGase 1 gene expression. We found that TPA, an activator of PKC, increases TGase 1 mRNA in cultured normal human epidermal keratinocytes and this effect is suppressed by the PKC inhibitors H-7 and staurosporine (20) . Dlugosz and Yuspa (26) have also shown that the effect of TPA is blocked by the PKC inhibitors, GF109203X and bryostatin 1, in cultured primary mouse epidermal keratinocytes. They also postulated that TGase 1 mRNA expression is regulated at the transcriptional level, from the results of a nuclear run-on assay. The transcriptional regulation by TPA has been confirmed in rabbit and human TGase 1 genes by means of a transient expression assay using the 5` upstream region of the genes (21, 38) . In this study, we show further direct evidence that nPKC, an isoform of PKC, regulates the transcriptional activation of the TGase 1 gene. This mechanism may also be functional in the epidermis of the skin, because the localization of nPKC is closely associated with that of TGase 1 mRNA in normal and psoriatic epidermis(16, 17, 34, 43) .

Deletion of the 5` upstream region of the human TGase 1 gene indicates that the sequence from -95 to -67 includes critical elements in response to both nPKC and TPA. The overexpression of nPKC with TPA induces no additional potentiation of its transcription in FRSK and nPKC without the kinase domain cannot increase the transcriptional activity. Thus, it is likely that TPA activates nPKC and the signal generated by phosphorylation is concentrated on the elements of the upstream region. Saunders et al.(21) have demonstrated the promoter activity of the proximal upstream region of rabbit TGase 1 gene. Its activation requires the sequence from -95 to -50 of the gene, the position of which is similar to that of human TGase 1 gene (12) . However, the homology of their sequences was not so high, suggesting a difference in TGase 1 gene regulation between the species.

As shown by immunoblotting, exogenous nPKC is well expressed in FRSK as well as HT-1080 fibroblastic cells. An increase in the expression levels of nPKC by exogenous introduction of an nPKC expression plasmid activates the transcription of TGase 1 in FRSK cells, but to a very limited extent in HT-1080 cells. Therefore, the signaling for TGase 1 gene expression is probably mediated by nPKC, but its presence is not necessarily sufficient to induce the transcriptional activation of the gene.

In terms of ability to induce TGase 1 transcription, nPKC was the most potent of all the PKC isoforms tested, cPKCalpha, cPKCbetaII, cPKC, nPKC, and aPKC. This prominent efficiency of nPKC seems to represent its selective importance in epidermal differentiation. It is localized in rough endoplasmic reticulum(48) , and, unlike cPKCs, it cannot be translocated to the plasma membrane by activation(45) . This unique feature of nPKC may be related to the induction of TGase 1 transcription. We also find that nPKC can induce TGase 1 transcription to some extent, suggesting possible contribution of the gene expression, although the PKC isoform is expressed in various organs including epidermis(45, 47) .

There is neither a conventional nor other TPA-responsive elements in the 5` upstream sequence from -95 to -67, which is critical to TGase 1 transcription(12) . We pointed out two Sp1 motifs in the 5` proximal upstream region of human TGase 1 gene(12) . Indeed, when a Sp1 expression plasmid was introduced into FRSK cells with a reporter plasmid pd-95, the luciferase activity increased (data not shown). Hence, we speculate that Sp1 or Sp1-related factors are involved in the transcriptional activation of TGase 1 gene. Further studies on the characterization of the signaling system via nPKC will provide new insights in the control of TGase 1 gene expression, which will lead to the elucidation of the molecular mechanisms involved in epidermal terminal differentiation and the molecular pathogenesis of keratinizing disorders, including lamellar ichthyosis.


FOOTNOTES

*
This work is supported by grants-in-aid from the Ministry of Education, Science and Culture of Japan and from the Ministry of Health and Welfare of Japan. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore by hereby marked ``advertisement'' in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

§
To whom all correspondence should be addressed: Department of Dermatology, Kyoto Prefectural University of Medicine, Kamigyo-ku, Kyoto 602, Japan. Fax: 81-75-251-5587; kyamanis{at}koto.kpu-m.ac.jp.

(^1)
The abbreviations used are: TGase 1, transglutaminase 1; TPA, 12-O-tetradecanoylphorbol-13-acetate; PKC, protein kinase C; cPKC, classical PKC; nPKC, novel PKC; aPKC, atypical PKC; PCR, polymerase chain reaction; PAGE, polyacrylamide gel electrophoresis; bp, base pair(s); kb, kilobase pair(s); DOTAP, N-[1-(2,3-dioleoyloxy)propyl]-N,N,N-trimethylammonium methylsulfate.


REFERENCES

  1. Fuchs, E., and Byrne, C. (1995) Curr. Opin. Genet. Dev. 4, 725-736
  2. Thacher, S. M., and Rice, R. H. (1985) Cell 40, 685-695 [Medline] [Order article via Infotrieve]
  3. Thacher, S. M. (1989) J. Invest. Dermatol. 89, 578-584
  4. Polakowska, R. R., and Goldsmith, L. A. (1991) in Physiology, Biochemistry, and Molecular Biology of the Skin (Goldsmith, L. A., ed) pp. 168-201, Oxford University Press, Inc., Oxford
  5. Rice, R. H., and Green, H. (1977) Cell 11, 417-422 [Medline] [Order article via Infotrieve]
  6. Takahashi, M., Tezuka, T., Kakegawa, H., and Katunuma, N. (1994) FEBS Lett. 340, 173-176 [CrossRef][Medline] [Order article via Infotrieve]
  7. Steinert, P. M., and Marekov, L. N. (1995) J. Biol. Chem. 270, 17702-17711 [Abstract/Free Full Text]
  8. Huber, M., Rettler, I., Bernasconi, K., Frenk, E., Lavrijsen, S. P. M., Ponec, M., Bon, A., Lautenschlager, S., Schorderet, D. F., and Hohl, D. (1995) Science 267, 525-528 [Medline] [Order article via Infotrieve]
  9. Russell, L. J., DiGiovanna, J. J., Rogers, G. R., Steinert, P. M., Hashem, N., Compton, J. G., and Bale, S. J. (1995) Nature Genet. 9, 279-283 [Medline] [Order article via Infotrieve]
  10. Parmentier, L., Blanchet-Bardon, C., Nguyen, S., Prud'homme, J.-F., Dubertret, L., and Weissenbach, J. (1995) Hum. Mol. Genet. 4, 1391-1395 [Abstract]
  11. Kim, I.-G., McBride, O. W., Wang, M., Kim, S.-Y., Idler, W. W., and Steinert, P. M. (1992) J. Biol. Chem. 267, 7710-7717 [Abstract/Free Full Text]
  12. Yamanishi, K., Inazawa, J., Liew, F.-M., Nonomura, K., Ariyama, T., Yasuno, H., Abe, T., Doi, H., Hirano, J., and Fukushima, S. (1992) J. Biol. Chem. 267, 17858-17863 [Abstract/Free Full Text]
  13. Phillips, M. A., Stewart, B. E., Quin, Q., Chakravarty, R., Floyd, E. E., Jetten, A. M., and Rice, R. H. (1990) Proc. Natl. Acad. Sci. U. S. A. 87, 9333-9337 [Abstract]
  14. Kim, H.-C., Idler, W. W., Kim, I.-G., Han, J. H., Chung, S.-I., and Steinert, P. M. (1991) J. Biol. Chem. 266, 536-539 [Abstract/Free Full Text]
  15. Yamanishi, K., Liew, F.-M., Konishi, K., Yasuno, H., Doi, H., Hirano, J., and Fukushima, S. (1991) Biochem. Biophys. Res. Commun. 175, 906-913 [Medline] [Order article via Infotrieve]
  16. Michel, S., Bernerd, F., Jetten, A. M., Floyd, E. E., Shroot, B., and Reichert, U. (1992) J. Invest. Dermatol. 98, 364-368 [Abstract]
  17. Nonomura, K., Yamanishi, K., Hosokawa, Y., Doi, H., Hirano, J., Fukushima, S., and Yasuno, H. (1993) Br. J. Dermatol. 128, 23-28 [Medline] [Order article via Infotrieve]
  18. Kim, S.-Y., Chung, S.-I., Yoneda, K., and Steinert, P. M. (1995) J. Invest. Dermatol. 104, 211-217 [Abstract]
  19. Lichti, U., and Yuspa, S. H. (1988) Cancer Res. 48, 74-81 [Abstract]
  20. Liew, F.-M., and Yamanishi, K. (1992) Exp. Cell Res. 202, 310-315 [Medline] [Order article via Infotrieve]
  21. Saunders, N. A., Bernacki, S. H., Vollberg, T. M., and Jetten, A. M. (1993) Mol. Endocrinol. 7, 387-398 [Abstract]
  22. Floyd, E. E., and Jetten, A. M. (1989) Mol. Cell. Biol. 9, 4846-4851 [Medline] [Order article via Infotrieve]
  23. Polakowska, R. R., Herting, E., and Goldsmith, L. A. (1991) J. Invest. Dermatol. 96, 285-288 [Abstract]
  24. Yada, Y., Polakowska, R. R., Okano, Y., and Nozawa, Y. (1993) Biochem. Biophys. Res. Commun. 190, 688-694 [CrossRef][Medline] [Order article via Infotrieve]
  25. Saunders, N. A., and Jetten, A. M. (1994) J. Biol. Chem. 269, 2016-2022 [Abstract/Free Full Text]
  26. Dlugosz, A. A., and Yuspa, S. H. (1994) J. Invest. Dermatol. 102, 409-414 [Abstract]
  27. Nishizuka, Y. (1984) Nature 308, 693-698 [Medline] [Order article via Infotrieve]
  28. Nishizuka, Y. (1986) Science 233, 305-312 [Medline] [Order article via Infotrieve]
  29. Nishizuka, Y. (1988) Nature 334, 661-665 [CrossRef][Medline] [Order article via Infotrieve]
  30. Nishizuka, Y. (1992) Science 258, 607-614 [Medline] [Order article via Infotrieve]
  31. Johannes, F.-J., Prestle, J., Eis, S., Oberhagemann, P., and Pfizenmaier, K. (1994) J. Biol. Chem. 269, 6140-6148 [Abstract/Free Full Text]
  32. Bacher, N., Zisman, Y., Berent, E., and Livneh, E. (1991) Mol. Cell. Biol. 11, 126-133 [Medline] [Order article via Infotrieve]
  33. Osada, S., Mizuno, K., Saido, T. C., Akita, Y., Suzuki, K., Kuroki, T., and Ohno, S. (1990) J. Biol. Chem. 265, 22434-22440 [Abstract/Free Full Text]
  34. Osada, S., Hashimoto, Y., Nomura, S., Kohno, Y., Cida, K., Tajima, O., Kubo, K., Akimoto, K., Koizumi, H., Kitamura, Y., Suzuki, K., Ohno, S., and Kuroki, T. (1993) Cell Growth Diff. 4, 167-175 [Abstract]
  35. Indo, K., and Wilson, R. B. (1977) J. Natl. Cancer Inst. 59, 867-880 [Medline] [Order article via Infotrieve]
  36. Indo, K., and Miyaji, H. (1979) J. Natl. Cancer Inst. 63, 1017-1027 [Medline] [Order article via Infotrieve]
  37. Rasheed, S., Nelson-Rees, W. A., Toth, E. M., Arnstein, P., and Gardner, B. (1974) Cancer 33, 1027-1033 [Medline] [Order article via Infotrieve]
  38. Yamada, K., Yamanishi, K., Kakizuka, A., Kibe, Y., Doi, H., and Yasuno, H. (1994) Biochem. Mol. Biol. Int. 34, 827-836 [Medline] [Order article via Infotrieve]
  39. Ohno, S., Akita, Y., Konno, Y., Imajoh, S., and Suzuki, K. (1988) Cell 53, 731-741 [Medline] [Order article via Infotrieve]
  40. MacGregor, G. R., and Caskey, C. T. (1989) Nucleic Acids Res. 17, 2365 [Medline] [Order article via Infotrieve]
  41. Laemmli, U. K. (1970) Nature 227, 680-685 [Medline] [Order article via Infotrieve]
  42. Hirai, S., Izumi, Y., Higa, K., Kaibuchi, K., Mizuno, K., Osada, S., Suzuki, K., and Ohno, S. (1994) EMBO J. 13, 2331-2340 [Abstract]
  43. Koizumi, H., Kohno, Y., Osada, S., Ohno, S., Ohkawara, A., and Kuroki, T. (1993) J. Invest. Dermatol. 101, 858-863 [Abstract]
  44. Greif, H., Ben-Chaim, J., Shimon, T., Bechor, E., Eldar, H., and Livneh, E. (1992) Mol. Cell. Biol. 12, 1304-1311 [Abstract]
  45. Reynolds, N. J., Baldassare, J. J., Henderson, P. A., Shuler, J. L., Ballas, L. M., Burns, D. J., Moomaw, C. R., and Fisher, G. J. (1994) J. Invest. Dermatol. 103, 364-369 [Abstract]
  46. Koyama, Y., Hachiya, T., Hagiwara, M., Kobayashi, M., Ohashi, K., Hoshino, T., Hidaka, H., and Marunouchi, T. (1990) J. Invest. Dermatol. 94, 677-680 [Abstract]
  47. Wetsel, W. C., Khan, W. A., Merchenthaler, I., Rivera, H., Halpern, A. E., Phung, H. M., Negro-Vilar, A., and Hannun, Y. A. (1992) J. Cell Biol. 117, 121-133 [Abstract]
  48. Chida, K., Sagara, H., Suzuki, Y., Murakami, A., Osada, S., Ohno, S., Hirosawa, K., and Kuroki, T. (1994) Mol. Cell. Biol. 14, 3782-3790 [Abstract]

©1996 by The American Society for Biochemistry and Molecular Biology, Inc.